315 related articles for article (PubMed ID: 30717908)
21. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery.
Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N
Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic thyroid cancer.
Ranganath R; Shah MA; Shah AR
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):387-91. PubMed ID: 26313900
[TBL] [Abstract][Full Text] [Related]
23. Spanish consensus for the management of patients with anaplastic cell thyroid carcinoma.
Jiménez-Fonseca P; Gómez Saez JM; Santamaria Sandi J; Capdevila J; Navarro Gonzalez E; Zafon Llopis C; Ramón Y Cajal Asensio T; Riesco-Eizaguirre G; Grande E; Galofré JC
Clin Transl Oncol; 2017 Jan; 19(1):12-20. PubMed ID: 27048161
[TBL] [Abstract][Full Text] [Related]
24. Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.
Song YS; Jung CK; Jung KC; Park YJ; Won JK
J Korean Med Sci; 2017 Oct; 32(10):1721-1726. PubMed ID: 28875621
[TBL] [Abstract][Full Text] [Related]
25. Anaplastic thyroid cancer:Improved understanding of what remains a deadly disease.
Cleere EF; Prunty S; O'Neill JP
Surgeon; 2024 Feb; 22(1):e48-e53. PubMed ID: 37866980
[TBL] [Abstract][Full Text] [Related]
26. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
[TBL] [Abstract][Full Text] [Related]
27. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
28. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Bible KC; Kebebew E; Brierley J; Brito JP; Cabanillas ME; Clark TJ; Di Cristofano A; Foote R; Giordano T; Kasperbauer J; Newbold K; Nikiforov YE; Randolph G; Rosenthal MS; Sawka AM; Shah M; Shaha A; Smallridge R; Wong-Clark CK
Thyroid; 2021 Mar; 31(3):337-386. PubMed ID: 33728999
[No Abstract] [Full Text] [Related]
29. Anaplastic thyroid carcinoma: review of treatment protocols.
Tiedje V; Stuschke M; Weber F; Dralle H; Moss L; Führer D
Endocr Relat Cancer; 2018 Mar; 25(3):R153-R161. PubMed ID: 29295821
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant famitinib and camrelizumab, a new combined therapy allowing surgical resection of the primary site for anaplastic thyroid carcinoma.
Yang S; Ji D; Xue F; Chen T; Wang Y; Ji Q
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1770. PubMed ID: 36535914
[TBL] [Abstract][Full Text] [Related]
31. Survival and prognostic factors of anaplastic thyroid carcinoma.
Paunovic IR; Sipetic SB; Zoric GV; Diklic AD; Savic DV; Marinkovic J; Zivaljevic VR
Acta Chir Belg; 2015; 115():62-7. PubMed ID: 26021793
[TBL] [Abstract][Full Text] [Related]
32. [Anaplastic carcinoma of the thyroid: diagnosis and treatment].
Giuffrida D; Lavenia G; Aiello RA; Di Blasi C; Gambera G; Pappalardo A; Petralia G; Ursino M; Failla G
Clin Ter; 2001; 152(4):255-61. PubMed ID: 11725619
[TBL] [Abstract][Full Text] [Related]
33. Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report.
Zheng L; Li L; He Q; Wang M; Ma Y; Zhu J; Li Y; Fu X; Zhang Y
Medicine (Baltimore); 2021 Aug; 100(32):e26138. PubMed ID: 34397868
[TBL] [Abstract][Full Text] [Related]
34. Survival in anaplastic thyroid cancer in relation to pre-existing goiter: a population-based study.
Steggink LC; van Dijk BA; Links TP; Plukker JT
Am J Surg; 2015 Jun; 209(6):1013-9. PubMed ID: 25242682
[TBL] [Abstract][Full Text] [Related]
35. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe.
Barbaro D; Lapi P; Viacava P; Torregrossa L
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370973
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of anaplastic thyroid carcinoma in the Kurdistan region of Iraq.
Mustafa DH; Ahmed BS; Haweizy RM; Dewana AM
BMC Surg; 2022 Oct; 22(1):364. PubMed ID: 36271386
[TBL] [Abstract][Full Text] [Related]
37. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
[TBL] [Abstract][Full Text] [Related]
38. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer.
Smallridge RC; Ain KB; Asa SL; Bible KC; Brierley JD; Burman KD; Kebebew E; Lee NY; Nikiforov YE; Rosenthal MS; Shah MH; Shaha AR; Tuttle RM;
Thyroid; 2012 Nov; 22(11):1104-39. PubMed ID: 23130564
[TBL] [Abstract][Full Text] [Related]
39. The value of multimodal treatment in anaplastic thyroid cancer patients with distant metastasis.
Guo H; Lin H
BMC Surg; 2024 Mar; 24(1):79. PubMed ID: 38438944
[TBL] [Abstract][Full Text] [Related]
40. Management of Anaplastic Thyroid Carcinoma: the Fruits from the ATC Research Consortium of Japan.
Sugitani I; Onoda N; Ito KI; Suzuki S
J Nippon Med Sch; 2018; 85(1):18-27. PubMed ID: 29540641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
